Expertise: Sars-CoV-2 vaccines and immunological surveillance
- Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
- Total publications:0 publications
Grant number: 0142005478
Grant search
Key facts
Disease
COVID-19Start & end year
20222022Known Financial Commitments (USD)
$132,500.38Funder
State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)Principal Investigator
Dziekan GeraldResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This mandate is intended to review the scientific literature available worldwide on the subject of vaccines against Sars-CoV-2 and immunological monitoring and to make the findings available to the FOPH. Until October 2022, regular summary reports will be prepared on the latest global findings on vaccines against Sars-CoV-2, e.g. on effectiveness or side effects, as well as on immunological parameters, e.g. on the protective correlate of SARS-CoV-2 antibodies and cellular immune reactions, on the duration of long-term protection after immunization (vaccination and/or infection) or on the level and duration of protection in risk groups. The publications considered will be provided to the FOPH in a suitable format.